Sun. Oct 18th, 2026
From the NewsForce247 Archive — originally published December 27, 2025. Stories move to the archive automatically after four weeks; they remain searchable and shareable.
COLUMBUS, Ohio — A new proposal before the Ohio General Assembly is sparking widespread discussion among healthcare professionals and policymakers. House Bill 629, officially titled the *Pharmacist Prescribing Authority Act*, would authorize licensed pharmacists across the state to prescribe medications for minor or “self-limiting” conditions such as sinus infections, rashes, or urinary tract infections.

Supporters of the measure say the bill could transform access to care—especially in rural and underserved communities where doctor shortages are common. “Pharmacists are often the most accessible healthcare professionals in a community,” said Rep. Erin Vance (R–Licking County), who introduced the bill earlier this month. “Allowing them to treat manageable, short-term conditions will help patients get care faster and reduce strain on emergency rooms and urgent care centers.”

Advertise your business here

The legislation outlines specific limits to pharmacists’ prescribing powers, restricting them to defined lists of conditions and medications approved by the State Board of Pharmacy and the Ohio Department of Health. It also requires pharmacists to complete certified clinical training programs and maintain communication with patients’ primary care providers.

Health experts are divided on the bill. The Ohio Medical Association has expressed cautious support but insists patient safety and care coordination must remain priorities. “We recognize the need to expand access,” said Dr. Marcus Liu, the association’s public policy chair. “However, safeguards must ensure that pharmacists aren’t placed in situations beyond their diagnostic scope.”

Advertise your business here

If passed, Ohio would join a growing number of states—including Idaho and New Mexico—that have expanded pharmacists’ clinical authority in recent years. Early data from those states suggest shorter wait times and improved access for minor ailments without increased safety risks.

The Pharmacy Board estimates that implementation could begin by mid-2026, pending regulatory review. For many pharmacists, the bill represents a long-awaited acknowledgment of their evolving role in modern healthcare.

Advertise your business here

“Pharmacy practice has changed—our training now includes clinical decision-making,” said Cleveland pharmacist Dana Matthews. “This bill empowers us to use those skills to serve patients who need timely, convenient care.”

The General Assembly is expected to debate House Bill 629 early next year when the legislative session resumes.

Advertise your business here
— NewsForce247.com

Leave a Reply

Your email address will not be published. Required fields are marked *